» Articles » PMID: 15940440

Reference Values of NT-proBNP Serum Concentrations in the Umbilical Cord Blood and in Healthy Neonates and Children

Overview
Journal Z Kardiol
Date 2005 Jun 9
PMID 15940440
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: N-terminal brain natriuretic peptide (NT-proBNP) is a neurohormonal substance secreted mainly by the cardiac myocytes of the left ventricle and to a less degree of the left atrium. The releasing mechanism is induced by an increased wall stress on the base of volume or pressure load of the ventricle. The physiologic actions of BNP are prohibition of the sympathetic activity, vasodilatation, natriuresis, diureses and inhibition of the renin-angiotensin system. Because of its high sensitivity and specifity in relation to the left ventricular incompetence, BNP as well as NTproBNP are well accepted markers of ventricular dysfunction. It was the aim of the study to establish reference values of NT-proBNP serum concentrations throughout childhood, in particular in the newborn age group.

Methods: In a cross sectional study, serum NT-proBNP concentrations were measured by an ElectroChemiLuminescenceImmunoAssay ("ECLIA" Roche) in the umbilical cord blood of 62 healthy full-term neonates and in 222 healthy probands from birth up to the age of 18 years.

Results: The concentration of NT-proBNP in the cord blood samples ranged from 281 to 2595 pg/ml (mean: 818 pg/ml). There was a significant increase in the first days of life followed by a rapid decrease during the first year and a further gradual decrease throughout infancy; beyond the 10(th) year of age normal adult values were approached.

Conclusions: The knowledge of the normal range of plasma NT-proBNP levels in healthy subjects during childhood serves as a non-invasive marker for differentiation of pathologic conditions such as acute myocarditis, hypertrophic or dilated cardiomyopathy, tachyarrhythmias and pulmonary hypertension.

Citing Articles

Newborn Screening for High-Risk Congenital Heart Disease by Dried Blood Spot Biomarker Analysis.

Clausen H, Friberg E, Lannering K, Koivu A, Sairanen M, Mellander M JAMA Netw Open. 2024; 7(6):e2418097.

PMID: 38913376 PMC: 11197454. DOI: 10.1001/jamanetworkopen.2024.18097.


Urinary NT-proBNP: A Useful Biomarker for the Diagnosis of Respiratory Distress in the Neonatal Population.

Christou E, Iliodromiti Z, Pouliakis A, Loukatou E, Varela P, Panagoulia A Cureus. 2023; 15(5):e39019.

PMID: 37323310 PMC: 10266900. DOI: 10.7759/cureus.39019.


Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment.

Siebers P, Gembruch U, Merz W, Recker F, Muller A, Strizek B Arch Gynecol Obstet. 2023; 309(4):1341-1351.

PMID: 36966429 PMC: 10894143. DOI: 10.1007/s00404-023-07006-8.


NT-proBNP Concentrations in the Umbilical Cord and Serum of Term Neonates: A Systematic Review and Meta-Analysis.

Christou E, Iliodromiti Z, Pouliakis A, Sokou R, Zantiotou M, Petropoulou C Diagnostics (Basel). 2022; 12(6).

PMID: 35741227 PMC: 9222102. DOI: 10.3390/diagnostics12061416.


Changes in Internal Cerebral Vein Pulsation and Intraventricular Hemorrhage in Extremely Preterm Infants.

Tanaka K, Matsumoto S, Minamitani Y, Imamura H, Yoshimatsu H, Nakamura T Am J Perinatol. 2022; 41(S 01):e37-e45.

PMID: 35381610 PMC: 11166026. DOI: 10.1055/a-1817-6638.


References
1.
Feller S, Gagelmann M, Forssmann W . Urodilatin: a newly described member of the ANP family. Trends Pharmacol Sci. 1989; 10(3):93-4. DOI: 10.1016/0165-6147(89)90199-5. View

2.
McCullough P, Omland T, Maisel A . B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med. 2003; 4(2):72-80. View

3.
Nir A, Bar-Oz B, Perles Z, Brooks R, Korach A, Rein A . N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr. 2004; 93(5):603-7. DOI: 10.1111/j.1651-2227.2004.tb02984.x. View

4.
Hobbs F, Davis R, Roalfe A, Hare R, Davies M, Kenkre J . Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ. 2002; 324(7352):1498. PMC: 116449. DOI: 10.1136/bmj.324.7352.1498. View

5.
Peacock 4th W . The B-type natriuretic peptide assay: a rapid test for heart failure. Cleve Clin J Med. 2002; 69(3):243-51. DOI: 10.3949/ccjm.69.3.243. View